Anzeige
Mehr »
Login
Samstag, 04.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
InnoCan Pharma: Multi-Milliarden-Wert in diesem Pennystock?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
46 Leser
Artikel bewerten:
(0)

ChemOutsourcing 2014 Attracts Record Number of Pharma Customers for September Show at Jersey Shore

LONG BRANCH, N.J., May 11, 2014 /PRNewswire/ --Pharma ChemOutsourcing President Mark Alexay today revealed that the 2014 show has attracted a record number of pharmaceutical and small molecule biotech company chemists all of whom are sourcing chemistry projects to support their pipelines.

"We have definitely on pace to attract 300 buyers to this year's show, far beyond the 190 in 2013," remarked Alexay. "Both increasing numbers from large Pharma like BMS, Pfizer, and GSK are providing some of the impetus, but ATTENDEES will be really pleased with the diversity of new biotech companies attending the show, many for the first time." http://chemoutsourcing.com/attendees.php

"Another benefit for 2014 is the evolving use of the exhibit halls for technical sessions and social events. In 2013 we moved the discussion panels and "Buyer Tables" into the halls to gather people together for longer periods. We learned that they were both good ideas but we had to observe the dynamic in action to draw meaningful conclusions. Now we know how to balance attendee, exhibitor, buyer, speaker, and social events in this key area." 30 unique Pharma Customers commented about the 2013 show: http://chemoutsourcing.com/ratings.php

An article published in November 2013 SP2 magazine entitled "The Rookie Returns" also detailed 2013 attendee experiences http://www.chemoutsourcing.com/downloads/chemovation_feb14.pdf

"The "Buyer Hosted Tables" turned out to be a good idea that will be further developed in 2014," Alexay went on to say. "This was another untried experiment that tuned out well for everyone. The trick at shows is to facilitate new meetings. Just because people are in the same room together doesn't guarantee this occurs.

The real surprise was the positive feedback from the buyers, the pharma customers. Now we know how to facilitate the initial contacts between buyers and exhibitors. Now, exhibitors and customers have a new tool to comfortably reach new prospects that they didn't before." The 2014 exhibitors: http://www.chemoutsourcing.com/sponsors.php

Lastly, Alexay mentioned that, "In order to generate the greatest value for buyers, I formed an advisory group composed just of such people to identify topics of particular interest to them. This will pay real dividends in 2014 because the show technical discussion sessions are clearly biased for pharma interest - this will attract more of them by serving their specific informational needs more effectively than in years past." The advisory group: http://chemoutsourcing.com/advisory.php

"Why shouldn't attendees be able to party on the beach and still get a year's worth of business done at the same time?" Alexay concluded. "ChemOutsourcing is fun and highly effective. We only have to listen to our attendees!" http://www.chemanager-online.com/en/topics/pharma-biotech-processing/chemoutsourcing-annual-cult-classic

Contact:
Mark Alexay
201-452-4023

SOURCE Pharma ChemOutsourcing

Lithium vs. Palladium - Zwei Rohstoff-Chancen traden
In diesem kostenfreien PDF-Report zeigt Experte Carsten Stork interessante Hintergründe zu den beiden Rohstoffen inkl. . Zudem gibt er Ihnen konkrete Produkte zum Nachhandeln an die Hand, inkl. WKNs.
Hier klicken
© 2014 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.